27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education

ABSTRACT IMPACT: A robust and collaborative network of expertise and services is essential for successful research commercialization, including timely and scalable educational support for CTSA institutions and individual faculty investigators with biomedical innovations. OBJECTIVES/GOALS: Leverage e...

Full description

Bibliographic Details
Main Authors: Samantha Cook, Stefan Koehler, Janani Ramaswamy, Kristen Wolff, Michelle Larkin, Jeanne Wright, Mona Bruch Moore, Jon Servoss
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121005537/type/journal_article
_version_ 1827993843513950208
author Samantha Cook
Stefan Koehler
Janani Ramaswamy
Kristen Wolff
Michelle Larkin
Jeanne Wright
Mona Bruch Moore
Jon Servoss
author_facet Samantha Cook
Stefan Koehler
Janani Ramaswamy
Kristen Wolff
Michelle Larkin
Jeanne Wright
Mona Bruch Moore
Jon Servoss
author_sort Samantha Cook
collection DOAJ
description ABSTRACT IMPACT: A robust and collaborative network of expertise and services is essential for successful research commercialization, including timely and scalable educational support for CTSA institutions and individual faculty investigators with biomedical innovations. OBJECTIVES/GOALS: Leverage expertise at the University of Michigan (UM) by creating collaborative and scalable interactive online courses to instruct and prepare internal and external faculty to navigate critical stages of life science academic research commercialization. METHODS/STUDY POPULATION: UM’s Fast Forward Medical Innovation created two online courses with the UM Office of Technology Transfer and the Michigan Institute for Clinical & Health Research (MICHR). Collaborative planning committees, with content and educational experts, set course goals and learning objectives based on audience needs (e.g. preparation for consultations, commercialization concepts, etc.). Draft content was developed, peer reviewed, and revised before Articulate Storyline was used to convert didactic content to active learning content (e.g. interactive slides, scenarios, quizzes, and forms). Pilot testing was conducted prior to the launch to faculty investigators throughout the UM network. RESULTS/ANTICIPATED RESULTS: Intellectual Property in the Academic Setting launched via the FFMI website and newsletter in July 2020 and has had 66 learners to date. Medical Device Regulations launched in October 2020 and has 22 learners. OTT and MICHR have successfully integrated the courses into their consultation process by requesting review from faculty investigators. We suspect that this will lead to more in-depth and meaningful conversation. Additionally, these courses have been integrated into an FFMI commercialization course to instruct on critical concepts. Evaluation and refinement for both use cases will ensue, as well as inform future collaborative courses. DISCUSSION/SIGNIFICANCE OF FINDINGS: Early results suggest that the courses are advantageous and can serve as a model for future collaborations. The opportunity to disseminate the courses across the CTSA network, as well as collaborate with other institutions, to scale localized expertise to a broader network is promising.
first_indexed 2024-04-10T04:32:09Z
format Article
id doaj.art-c30a8751181b46958e894a5bc1c6d0e6
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:32:09Z
publishDate 2021-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-c30a8751181b46958e894a5bc1c6d0e62023-03-10T07:52:04ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-03-015585810.1017/cts.2021.55327363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization EducationSamantha Cook0Stefan Koehler1Janani Ramaswamy2Kristen Wolff3Michelle Larkin4Jeanne Wright5Mona Bruch Moore6Jon Servoss7Michigan Medicine, University of MichiganUniversity of MichiganUniversity of MichiganUniversity of MichiganMichigan Medicine, University of MichiganMichigan Medicine, University of MichiganMichigan Medicine, University of MichiganMichigan Medicine, University of MichiganABSTRACT IMPACT: A robust and collaborative network of expertise and services is essential for successful research commercialization, including timely and scalable educational support for CTSA institutions and individual faculty investigators with biomedical innovations. OBJECTIVES/GOALS: Leverage expertise at the University of Michigan (UM) by creating collaborative and scalable interactive online courses to instruct and prepare internal and external faculty to navigate critical stages of life science academic research commercialization. METHODS/STUDY POPULATION: UM’s Fast Forward Medical Innovation created two online courses with the UM Office of Technology Transfer and the Michigan Institute for Clinical & Health Research (MICHR). Collaborative planning committees, with content and educational experts, set course goals and learning objectives based on audience needs (e.g. preparation for consultations, commercialization concepts, etc.). Draft content was developed, peer reviewed, and revised before Articulate Storyline was used to convert didactic content to active learning content (e.g. interactive slides, scenarios, quizzes, and forms). Pilot testing was conducted prior to the launch to faculty investigators throughout the UM network. RESULTS/ANTICIPATED RESULTS: Intellectual Property in the Academic Setting launched via the FFMI website and newsletter in July 2020 and has had 66 learners to date. Medical Device Regulations launched in October 2020 and has 22 learners. OTT and MICHR have successfully integrated the courses into their consultation process by requesting review from faculty investigators. We suspect that this will lead to more in-depth and meaningful conversation. Additionally, these courses have been integrated into an FFMI commercialization course to instruct on critical concepts. Evaluation and refinement for both use cases will ensue, as well as inform future collaborative courses. DISCUSSION/SIGNIFICANCE OF FINDINGS: Early results suggest that the courses are advantageous and can serve as a model for future collaborations. The opportunity to disseminate the courses across the CTSA network, as well as collaborate with other institutions, to scale localized expertise to a broader network is promising.https://www.cambridge.org/core/product/identifier/S2059866121005537/type/journal_article
spellingShingle Samantha Cook
Stefan Koehler
Janani Ramaswamy
Kristen Wolff
Michelle Larkin
Jeanne Wright
Mona Bruch Moore
Jon Servoss
27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
Journal of Clinical and Translational Science
title 27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
title_full 27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
title_fullStr 27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
title_full_unstemmed 27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
title_short 27363 Forging Collaboration and the Scalable Dissemination of Biomedical Research Commercialization Education
title_sort 27363 forging collaboration and the scalable dissemination of biomedical research commercialization education
url https://www.cambridge.org/core/product/identifier/S2059866121005537/type/journal_article
work_keys_str_mv AT samanthacook 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT stefankoehler 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT jananiramaswamy 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT kristenwolff 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT michellelarkin 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT jeannewright 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT monabruchmoore 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation
AT jonservoss 27363forgingcollaborationandthescalabledisseminationofbiomedicalresearchcommercializationeducation